NATURAL BIOMATERIALS MARKET ANALYSIS

Natural Biomaterials Market, By Product Type (Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin/chitosan, Others), By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Neurological Disorders/Central Nervous Systems, Tissue Engineering, Ophthalmology, and Others), and By Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Recent Developments

In June 2022, DuPont, a global leader in innovation through technology-based materials and solutions, completed the previously announced sale of its Biomaterials business unit to the Huafon Group for approximately US$ 240 million.
In March 2022, Evonik Industries, a stock-listed German specialty chemicals company commercially launched EUDRATEC Fasteric used for enteric fortification and prompt release in the upper smaller intestine, which is a platform of oral drug delivery technology directly over the released target. This product development improved the biocompatibility, safety, and performance of implantable products used by medical device customers and further strengthened Evonik’s growth.